07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

concentrations control distribution and therefore, numbers of naïve versus effector CD4 and CD8 T<br />

cells.(6) It is generally accepted that lower CD4 T cell counts are seen in the morning compared to the<br />

evening(9) and during summer compared to winter.(10) These data therefore indicate that timing and<br />

consistency in timing of blood collection is critical when serially monitoring patients for lymphocyte<br />

subsets.<br />

Useful For: Diagnosis of hyper-IgM syndromes, specifically X-linked hyper-IgM (HIGM1) and<br />

autosomal recessive hyper-IgM type 3 (HIGM3) Evaluation of isotype class-switching defects<br />

Interpretation: An interpretive report will be provided. The absence of CD40LG on activated T cells<br />

is consistent with X-linked hyper-IgM syndrome (HIGM1). The presence of CD40LG on activated T cells<br />

is not consistent with HIGM1. The presence of a positive and negative population for CD40LG is<br />

consistent with HIGM1 carrier status (mosaic). Negative CD40-muIg staining is consistent with HIGM1.<br />

Positive CD40-muIg staining is not consistent with HIGM1. Some patients (~20%) show absent<br />

(negative) staining with the CD40-muIg antibody, while there is positive staining for surface CD40LG on<br />

activated T cells. This dichotomy is due to the presence of specific mutations in the CD40LG gene that<br />

permit normal surface expression of the protein but abrogate function. Therefore, measurement of the<br />

receptor-ligand binding function using the chimeric CD40-muIg antibody improves the specificity of the<br />

assay, enabling identification of CD40LG-deficient patients who would be missed otherwise. The absence<br />

of CD40LG protein expression or CD40-muIg binding is considered confirmatory for HIGM1. Genetic<br />

testing is not necessary to confirm the diagnosis, but may be performed to identify the specific mutation<br />

involved. The absence of CD40 on B cells is consistent with autosomal recessive hyper-IgM type 3<br />

(HIGM3). The presence of CD40 on B cells is not consistent with HIGM3. Reduced or absent<br />

class-switched memory B cells (CD27+IgM-IgD-) is consistent with a defect in isotype class-switching.<br />

Normal numbers of class-switched memory B cells indicates the lack of an isotype class-switching defect.<br />

Reference Values:<br />

B-Cell Subset Pediatric Reference Values (n=98)<br />

Results Expressed as a Percentage of Total Lymphocytes Percentage Absolute Count (Cells/mcL)<br />

CD19+ 4.3-23.2 92.0-792.0<br />

CD19+ CD20+ 4.2-24.1 85.0-767.9<br />

Results Expressed as a Percentage of CD19+ B Cells Percentage Absolute Count (Cells/mcL)<br />

CD19+ CD27+ 4.6-49.1 9.4-136.0<br />

CD19+ CD27+ IgM+ IgD+ 0.2-12.0 0.8-42.7<br />

CD19+ CD27+ IgM- IgD- 1.9-30.4 5.2-74.2<br />

CD19+ CD27+ IgM+ IgD- 0.3-13.1 0.8-37.8<br />

CD19+ IgM+ 32.8-82.6 46.0-596.0<br />

CD19+ CD38+ IgM- 2.9-51.8 8.2-275.1<br />

CD19+ CD38+ IgM+ 7.6-48.6 14.2-229.6<br />

CD19+ CD21+ 94.5-99.8 89.4-780.1<br />

CD19+ CD21- 0.2-5.5 0.9-25.5<br />

B-Cell Subset Adult Reference Values (n=96)<br />

Results Expressed as a Percentage of Total Lymphocytes Percentage Absolute Count (Cells/mcL)<br />

CD19+ 2.8-17.4 90.0-539.0<br />

CD19+ CD20+ 3.2-16.8 95.0-580.8<br />

Results Expressed as a Percentage of<br />

CD19+ B Cells<br />

Percentage Absolute Count (Cells/mcL)<br />

CD19+ CD27+ 6.3-52.8 18.0-145.0<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 991

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!